BML Capital Management »

CarMax shares owned by BML Capital Management

Quarter-by-quarter ownership of CarMax (KMX) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in CarMax

Tip: Access up to 7 years of quarterly data

All positions including CarMax held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CarMax by BML Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 155k 38.64

More positions owned by BML Capital Management

Aclaris Therapeutics (ACRS)
Atea Pharmaceuticals (AVIR)
Oramed Pharmaceuticals Com New (ORMP)
Instil Bio Com New (TIL)
Pmv Pharmaceuticals (PMVP)
CarMax (KMX)
Kezar Life Sciences Com New (KZR)
Target Corporation (TGT)
Carvana Cl A Put Option (CVNA)
Outset Med Com New (OM)
Pliant Therapeutics (PLRX)
Imagenebio (IMA)
Connect Biopharma Hldgs SHS (CNTB)
Wal-Mart Stores Put Option (WMT)
Tesla Motors Put Option (TSLA)

View all positions for BML Capital Management

Top funds holding CarMax

BlackRock
Vanguard Group
State Street Corporation
Henderson Group
PRIMECAP Management Company
Diamond Hill Capital Management
Norges Bank Investment Management
Dimensional Fund Advisors
AQR Capital Management
Vulcan Value Partners
First Pacific Advisors
Baird Financial
Geode Capital Management
Manufacturers Life Insurance Company
Susquehanna International

View all funds holding CarMax